Literature DB >> 35936110

A Neonatal Case of Mild Encephalopathy/Encephalitis with a Reversible Splenial Lesion.

Yuzuki Oki1, Tomohide Yoshida2, Akira Yogi3, Shingo Kurokawa1, Hideki Goya2, Mayumi Tsukayama2, Sadao Nakamura1, Keiko Mekaru2, Koichi Nakanishi1.   

Abstract

The neurological symptoms of pediatric mild encephalopathy/encephalitis with a reversible splenial lesion (MERS) are mild and have a good prognosis. However, some aspects of neonatal MERS are unclear due to a lack of clinical knowledge. We present a neonatal case of MERS with features of poor activity and prolonged poor oxygenation after birth without asphyxia. He was diagnosed with MERS by brain magnetic resonance imaging (MRI) on day10, because the diffusion restriction of the splenium of the corpus callosum (SCC) seen on diffusion-weighted MRI on day 5 was attenuating. He was discharged due to good progress on day 26, but growth issues and developmental delay were observed in the follow up from 1-10 months. In rare neonatal cases, many aspects of the clinical course and prognosis are thus unclear. MERS should be considered in newborns who show unexplained non-neural or other encephalopathic symptoms.
© The Author(s) 2022.

Entities:  

Keywords:  developmental delay; encephalitis; epileptic encephalopathy; magnetic resonance imaging; neonate

Year:  2022        PMID: 35936110      PMCID: PMC9346259          DOI: 10.1177/2329048X221111716

Source DB:  PubMed          Journal:  Child Neurol Open        ISSN: 2329-048X


  8 in total

1.  Neonate showing reversible splenial lesion.

Authors:  Jun-Ichi Takanashi; Masayuki Maeda; Masaharu Hayashi
Journal:  Arch Neurol       Date:  2005-09

2.  Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes.

Authors:  Ai Hoshino; Makiko Saitoh; Akira Oka; Akihisa Okumura; Masaya Kubota; Yoshiaki Saito; Jun-Ichi Takanashi; Shinichi Hirose; Takanori Yamagata; Hideo Yamanouchi; Masashi Mizuguchi
Journal:  Brain Dev       Date:  2011-09-15       Impact factor: 1.961

3.  Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).

Authors:  Jun-ichi Takanashi; Atsushi Imamura; Fumio Hayakawa; Hitoshi Terada
Journal:  J Neurol Sci       Date:  2010-03-16       Impact factor: 3.181

4.  Mild encephalopathy/encephalitis with a reversible splenial lesion (MERS): A report of five neonatal cases.

Authors:  Dan Sun; Wen-Hong Chen; Suraj Baralc; Juan Wang; Zhi-Sheng Liu; Yuan-Peng Xia; Lei Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

5.  Widening spectrum of a reversible splenial lesion with transiently reduced diffusion.

Authors:  J Takanashi; A J Barkovich; T Shiihara; H Tada; M Kawatani; H Tsukahara; M Kikuchi; M Maeda
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

6.  Encephalopathy with a reversible splenial lesion is associated with hyponatremia.

Authors:  Jun-ichi Takanashi; Hiroko Tada; Masayuki Maeda; Motomasa Suzuki; Hitoshi Terada; A James Barkovich
Journal:  Brain Dev       Date:  2008-05-19       Impact factor: 1.961

Review 7.  Two newly proposed infectious encephalitis/encephalopathy syndromes.

Authors:  Jun-ichi Takanashi
Journal:  Brain Dev       Date:  2009-03-31       Impact factor: 1.961

8.  Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey.

Authors:  Tsuyoshi Isojima; Noriko Kato; Yoshiya Ito; Susumu Kanzaki; Mitsunori Murata
Journal:  Clin Pediatr Endocrinol       Date:  2016-04-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.